Nabumetone

Chemical formula: C₁₅H₁₆O₂  Molecular mass: 228.286 g/mol  PubChem compound: 4409

Therapeutic indications

Nabumetone is indicated for:

Osteoarthritis, rheumatoid arthritis

Population group: only adults (18 years old or older)

For use in osteoarthritis and rheumatoid arthritis requiring anti-inflammatory and analgesic treatment.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Nabumetone is contraindicated in the following cases:

Pregnancy

Pregnancy

Lactation

Lactation

Severe hepatic failure

Hepatic failure stage IV

Severe heart failure

Heart failure

Peptic ulcer

at least one of
Peptic ulcer
H/O: peptic ulcer

History of gastrointestinal bleeding or perforation related to previous NSAIDs therapy, recurrent peptic ulcer

at least one of
Duodenal ulcer caused by non-steroidal anti-inflammatory drug
Chronic peptic ulcer

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2018: NABUMETONE Film-coated tablet
Structured Product Labeling (SPL) 2020: RELAFEN Tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈